The global prescription opioid market, valued at $23.94B in 2025, is projected to grow at a CAGR of 3.75% until 2033. This report analyzes market drivers, trends, restraints, and key players like Teva, Mallinckrodt, and Purdue Pharma, offering insights into regional market share and opioid types (codeine, fentanyl, morphine). Discover the evolving landscape of opioid pain management and the challenges ahead.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.